Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Inhibitory concentration of different ginsenosides on proliferation of SNU449 Human Liver Cancer Cells

From: Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells

Ginsenoside IC50*
mg/ml μM
Rh2 0.04 55.45
Rk1 0.08 100.00
Rk3 0.12 186.96
20S-Rg3 0.16 199.15
  1. * IC50= 50% inhibition concentration (calculated using Calcusyn software)
  2. Note: The cells were exposed to the ginsenosides at 0.1, 1, 5, 10, 50, 100, 200 and 250 mg/ml for 48 hours. Ginsenoside Rh2 showed the lowest IC50 value, followed by Rk1, Rk3 and 20S-Rg3.